RUA Life Sciences is a newly-formed medical device business created by the acquisition of RUA Medical Devices Ltd by AorTech International plc in April 2020. As a holding company, RUA Life Sciences operates four businesses with the aim of improving the lives of patients through the use of their polymer technology, specifically Elast-EonTM. This technology is the world's leading long-term implantable polyurethane, making it a valuable asset in enhancing and enabling medical devices.